EUCTR2004-001373-26-ES进行中（未招募）1 期
Multicentre clinical trial to evaluate the efficacy and safety of dexketoprofen trometamol (50 mg t.i.d.) versus ketorolac (30 mg t.i.d.) and placebo by intravenous route, as part of balanced analgesic therapy with morphine, followed by an oral dosing, in the treatment of postoperative pain
aboratorios Menarini, S.A0 个研究点目标入组 0 人开始时间: 2004年10月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients of both sexes, aged between 18 and 70 years inclusively.
- •2. Patients with body weigth between 60 and 100 kg, both included.
- •3. Patients after elective orthopaedic surgery (hip replacement) with spinal anesthesia.
- •4. Patients with grade I, II or III ASA physical status.
- •5. Patients capable of understanding the information provided for patients and who have given their written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients with a history of peptic ulcer, gastric disease due to NSAIDs or gastrointestinal bleeding.
- •2. Patients with asthma or a history of bronchospasm, nasal polyps or angioedema.
- •3. Patients with moderate-severe or decompensated renal, hepatic, or respiratory diseases.
- •4. Presence of systemic infection or local infection on the surgical site before surgery.
- •5. Patients with non-controlled diabetes, heart failure or hypertension.
- •6. Patients with coagulation disorders.
- •7. Patients currently being treated for any type of psychiatric disease.
- •8. Patients with brain injury or increased intracranial pressure.
- •9. Patients with hypothyroidism, adrenal failure or myasthenia gravis.
- •10. Patients with intestinal ileus, ulcerative colitis or Crohn´s disease.
- •11. Patients with suspected alcohol and/or drug addiction.
- •12. Patients with hypersensitivity or intolerance to the tested drugs or to other NSAIDs, salicylic acid, or opiates.
- •13. Patients receiving concomitant treatment or who have received treatment in the previous 48 hours, with any of the following drugs:
- •AntiepilepticsMethotrexate
- •AntipsychoticsCylosporin
- •MAOIsLithium
- •Oral anticoagulantsSystemic steroids
- •14. Patients who had taken any NSAID or analgesic drug (excepting paracetamol) within twelve hours of surgery.
- •15. Patients receiving concomitant treatment with other investigational drugs or who had participated in another clinical trial two months before the inclusion in the study.
- •16. Nursing or pregnant women. A pregnancy test will be done to all fertile women and should be negative to include the patient in the study.
- •17. Patients unable to understand the nature of the study by any reason (culture, language comprehension, …) or whom the investigator suspects may not collaborate in the study.
研究者
相似试验
招募中
2 期
Multicenter clinical trial to evaluate the efficacy of rituximab combination chemotherapy for children or AYAswith localized mature B-cell lymphomaJPRN-jRCTs041210104Sekimizu Masahiro100
尚未招募
不适用
Comparative clinical study of eye drops in dry eye syndromeDiseases of the eye and adnexaKCT0004516Kangbuk Samsung Medical Center60
尚未招募
不适用
Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive ImpairmentMental and behavioural disordersKCT0007184Inha University Hospital100
已完成
不适用
Multicenter clinical study to assess the effectiveness and safety of Aquala liner in total hip arthroplasty (THA)Hip disorders including osteoarthritisJPRN-UMIN000008730Graduate School of Medicine, The University of Tokyo760
已完成
不适用
Multicenter clinical study to assess the effectiveness and safety of Trident II in total hip arthroplasty (THA)Osteoarthritis, Femoral head necrosis, Rheumatoid arthritis, fractureJPRN-UMIN000043715Stryker Japan K.K.191